Q1 2023 Holdings
Filed 2023-05-15 | 83 holdings | $3.0B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Arvinas Inc(ARVN) | COM | 04335A105 | $116.8M | 4,273,900 | 3.9% |
| Surgery Partners Inc(SGRY) | COM | 86881A100 | $115.7M | 3,355,900 | 3.8% |
| BIO RAD Labs Inc(BIO) | CL A | 090572207 | $106.1M | 221,500 | 3.5% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $104.6M | 280,700 | 3.5% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $99.2M | 677,900 | 3.3% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $97.9M | 119,100 | 3.2% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $93.6M | 2,447,000 | 3.1% |
| Tenet Healthcare Corp(THC) | COM NEW | 88033G407 | $87.5M | 1,472,000 | 2.9% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $85.3M | 2,126,900 | 2.8% |
| Universal Hlth Svcs Inc(UHS) | CL B | 913903100 | $85.2M | 670,000 | 2.8% |
| Acadia Healthcare Company in(ACHC) | COM | 00404A109 | $84.2M | 1,165,300 | 2.8% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $82.6M | 815,700 | 2.7% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $81.6M | 3,865,300 | 2.7% |
| Karuna Therapeutics Inc | COM | 48576A100 | $73.3M | 403,800 | 2.4% |
| Becton Dickinson & Co(BDX) | COM | 075887109 | $71.3M | 288,000 | 2.4% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $70.9M | 2,665,000 | 2.4% |
| Zoetis Inc(ZTS) | CL A | 98978V103 | $67.8M | 407,500 | 2.3% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $64.2M | 1,917,800 | 2.1% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $63.8M | 600,000 | 2.1% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $57.3M | 416,000 | 1.9% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $54.0M | 1,120,500 | 1.8% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $51.8M | 1,068,200 | 1.7% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $50.4M | 3,673,400 | 1.7% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $50.4M | 2,929,300 | 1.7% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $45.5M | 1,869,200 | 1.5% |
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $44.2M | 1,741,300 | 1.5% |
| Pacific Biosciences Calif in(PACB) | COM | 69404D108 | $44.1M | 3,812,600 | 1.5% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $42.5M | 850,000 | 1.4% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $38.2M | 619,200 | 1.3% |
| VIR Biotechnology Inc(VIR) | COM | 92764N102 | $38.2M | 1,640,200 | 1.3% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $38.1M | 769,800 | 1.3% |
| Karyopharm Therapeutics Inc(KPTIEUR) | COM | 48576U106 | $37.5M | 9,633,911 | 1.2% |
| Abbott Labs(ABT) | COM | 002824100 | $35.8M | 354,000 | 1.2% |
| Biogen Inc(BIIB) | COM | 09062X103 | $35.8M | 128,800 | 1.2% |
| Bellus Health Inc New(BLU) | COM NEW | 07987C204 | $32.8M | 4,553,577 | 1.1% |
| Icon PLC(ICLR) | SHS | G4705A100 | $30.5M | 142,900 | 1.0% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $29.2M | 300,575 | 1.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $29.1M | 1,344,800 | 1.0% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $28.1M | 1,842,976 | 0.9% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $26.4M | 900,000 | 0.9% |
| Curevac N V | COM | N2451R105 | $24.7M | 3,550,000 | 0.8% |
| Avantor Inc(AVTR) | COM | 05352A100 | $23.8M | 1,125,000 | 0.8% |
| Nanostring Technologies Inc(NSTGEUR) | COM | 63009R109 | $21.9M | 2,217,000 | 0.7% |
| Fusion Pharmaceuticals Inc | COM | 36118A100 | $21.5M | 5,700,000 | 0.7% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $21.3M | 1,244,400 | 0.7% |
| Kezar Life Sciences Inc | COM | 49372L100 | $20.4M | 6,519,400 | 0.7% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $20.3M | 1,487,200 | 0.7% |
| Amerisourcebergen Corp(COR) | COM | 03073E105 | $20.3M | 126,600 | 0.7% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $19.8M | 1,263,800 | 0.7% |
| Verve Therapeutics Inc | COM | 92539P101 | $19.5M | 1,351,700 | 0.6% |